Cargando…
RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant
Background & Aims Present therapy for chronic hepatitis B attains control only in limited proportions. Small interfering RNA (siRNA) offers a new tool with potential therapeutic applications for hepatitis B virus (HBV). Given the importance of sequence identity in the effectiveness of siRNA and...
Autores principales: | Wu, Hui-Lin, Huang, Li-Rung, Huang, Chuan-Chuan, Lai, Hsiao-Lei, Liu, Chun-Jen, Huang, Yu-Tzu, Hsu, Yun-Wei, Lu, Cheng-Yi, Chen, Ding-Shinn, Chen, Pei-Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Gastroenterological Association. Published by Elsevier Inc.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094679/ https://www.ncbi.nlm.nih.gov/pubmed/15765406 http://dx.doi.org/10.1053/j.gastro.2004.12.007 |
Ejemplares similares
-
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
por: Yang, Hwai-I, et al.
Publicado: (2008) -
Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients
por: Wu, Hui-Lin, et al.
Publicado: (2016) -
The emerging role of hepatitis B virus Pre-S2 deletion mutant proteins in HBV tumorigenesis
por: Su, Ih-Jen, et al.
Publicado: (2014) -
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017) -
Chemical interference with DSIF complex formation lowers synthesis of mutant huntingtin gene products and curtails mutant phenotypes
por: Deng, Ning, et al.
Publicado: (2022)